Similar articles

• [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].

  Limmer S, Ittel TH, Wietholtz H. Limmer S, et al. Z Gastroenterol. 2003 Aug;41(8):719-28. doi: 10.1055/s-2003-41208. Z Gastroenterol. 2003. PMID: 12910426 Review. German.
• Upper gastrointestinal complications: the causes, consequences, and clinical outcomes.

  [No authors listed] [No authors listed] Am J Manag Care. 2001 Sep;7(12 Suppl):S397-401. Am J Manag Care. 2001. PMID: 11570031 Review.
• Strategies to reduce the GI risks of antiplatelet therapy.

  Scheiman JM. Scheiman JM. Rev Cardiovasc Med. 2005;6 Suppl 4:S23-31. Rev Cardiovasc Med. 2005. PMID: 17710073 Review.
• Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.

  Lanas A. Lanas A. Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S37-42. Ital J Gastroenterol Hepatol. 1999. PMID: 10379468 Review.
• Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.

  Chan FK, Graham DY. Chan FK, et al. Aliment Pharmacol Ther. 2004 May 15;19(10):1051-61. doi: 10.1111/j.1365-2036.2004.01935.x. Aliment Pharmacol Ther. 2004. PMID: 15142194 Review.